Literature DB >> 22006981

Megalencephalic leucoencephalopathy with cysts: defect in chloride currents and cell volume regulation.

Margreet C Ridder1, Ilja Boor, Johannes C Lodder, Nienke L Postma, Xavier Capdevila-Nortes, Anna Duarri, Arjen B Brussaard, Raúl Estévez, Gert C Scheper, Huibert D Mansvelder, Marjo S van der Knaap.   

Abstract

Megalencephalic leucoencephalopathy with subcortical cysts is a genetic brain disorder with onset in early childhood. Affected infants develop macrocephaly within the first year of life, after several years followed by slowly progressive, incapacitating cerebellar ataxia and spasticity. From early on, magnetic resonance imaging shows diffuse signal abnormality and swelling of the cerebral white matter, with evidence of highly increased white matter water content. In most patients, the disease is caused by mutations in the gene MLC1, which encodes a plasma membrane protein almost exclusively expressed in brain and at lower levels in leucocytes. Within the brain, MLC1 is mainly located in astrocyte-astrocyte junctions adjacent to the blood-brain and cereborspinal fluid-brain barriers. Thus far, the function of MLC1 has remained unknown. We tested the hypothesis that MLC1 mutations cause a defect in ion currents involved in water and ion homeostasis, resulting in cerebral white matter oedema. Using whole-cell patch clamp studies we demonstrated an association between MLC1 expression and anion channel activity in different cell types, most importantly astrocytes. The currents were absent in chloride-free medium and in cells with disease-causing MLC1 mutations. MLC1-dependent currents were greatly enhanced by hypotonic pretreatment causing cell swelling, while ion channel blockers, including Tamoxifen, abolished the currents. Down regulation of endogenous MLC1 expression in astrocytes by small interfering RNA greatly reduced the activity of this channel, which was rescued by overexpression of normal MLC1. The current-voltage relationship and the pharmacological profiles of the currents indicated that the channel activated by MLC1 expression is a volume-regulated anion channel. Such channels are involved in regulatory volume decrease. We showed that regulatory volume decrease was hampered in lymphoblasts from patients with megalencephalic leucoencephalopathy. A similar trend was observed in astrocytes with decreased MLC1 expression; this effect was rescued by overexpression of normal MLC1. In the present study, we show that absence or mutations of the MLC1 protein negatively impact both volume-regulated anion channel activity and regulatory volume decrease, indicating that megalencephalic leucoencephalopathy is caused by a disturbance of cell volume regulation mediated by chloride transport.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 22006981     DOI: 10.1093/brain/awr255

Source DB:  PubMed          Journal:  Brain        ISSN: 0006-8950            Impact factor:   13.501


  27 in total

1.  Megalencephalic Leukoencephalopathy with Subcortical Cysts Protein-1 (MLC1) Counteracts Astrocyte Activation in Response to Inflammatory Signals.

Authors:  Maria Stefania Brignone; Angela Lanciotti; Barbara Serafini; Cinzia Mallozzi; Marco Sbriccoli; Caterina Veroni; Paola Molinari; Xabier Elorza-Vidal; Tamara Corinna Petrucci; Raul Estévez; Elena Ambrosini
Journal:  Mol Neurobiol       Date:  2019-06-17       Impact factor: 5.590

2.  Megalencephalic leukoencephalopathy with subcortical cysts type 1 (MLC1) due to a homozygous deep intronic splicing mutation (c.895-226T>G) abrogated in vitro using an antisense morpholino oligonucleotide.

Authors:  Cecilia Mancini; Giovanna Vaula; Laura Scalzitti; Simona Cavalieri; Enrico Bertini; Chiara Aiello; Cinzia Lucchini; Richard A Gatti; Alessandro Brussino; Alfredo Brusco
Journal:  Neurogenetics       Date:  2012-05-03       Impact factor: 2.660

Review 3.  White matter astrocytes in health and disease.

Authors:  I Lundgaard; M J Osório; B T Kress; S Sanggaard; M Nedergaard
Journal:  Neuroscience       Date:  2013-11-11       Impact factor: 3.590

4.  Megalencephalic leukoencephalopathy with cysts in twelve Egyptian patients: novel mutations in MLC1 and HEPACAM and a founder effect.

Authors:  Ghada M H Abdel-Salam; Mohamed S Abdel-Hamid; Samira I Ismail; Heba Hosny; Tarek Omar; Laila Effat; Mona S Aglan; Samia A Temtamy; Maha S Zaki
Journal:  Metab Brain Dis       Date:  2016-07-07       Impact factor: 3.584

Review 5.  From Pinocytosis to Methuosis-Fluid Consumption as a Risk Factor for Cell Death.

Authors:  Markus Ritter; Nikolaus Bresgen; Hubert H Kerschbaum
Journal:  Front Cell Dev Biol       Date:  2021-06-23

6.  Structural determinants of interaction, trafficking and function in the ClC-2/MLC1 subunit GlialCAM involved in leukodystrophy.

Authors:  Xavier Capdevila-Nortes; Elena Jeworutzki; Xabier Elorza-Vidal; Alejandro Barrallo-Gimeno; Michael Pusch; Raúl Estévez
Journal:  J Physiol       Date:  2015-06-23       Impact factor: 5.182

7.  Short-coherence off-axis holographic phase microscopy of live cell dynamics.

Authors:  Stefan Witte; Andrius Plauşka; Margreet C Ridder; Laura van Berge; Huibert D Mansvelder; Marie Louise Groot
Journal:  Biomed Opt Express       Date:  2012-08-22       Impact factor: 3.732

8.  Functional studies of MLC1 mutations in Chinese patients with megalencephalic leukoencephalopathy with subcortical cysts.

Authors:  Han Xie; Jingmin Wang; Ajit Singh Dhaunchak; Jing Shang; Liping Kou; Mangmang Guo; Ye Wu; Qiang Gu; David Colman; Xiru Wu; Yuwu Jiang
Journal:  PLoS One       Date:  2012-03-05       Impact factor: 3.240

9.  GlialCAM, a protein defective in a leukodystrophy, serves as a ClC-2 Cl(-) channel auxiliary subunit.

Authors:  Elena Jeworutzki; Tania López-Hernández; Xavier Capdevila-Nortes; Sònia Sirisi; Luiza Bengtsson; Marisol Montolio; Giovanni Zifarelli; Tanit Arnedo; Catrin S Müller; Uwe Schulte; Virginia Nunes; Albert Martínez; Thomas J Jentsch; Xavier Gasull; Michael Pusch; Raúl Estévez
Journal:  Neuron       Date:  2012-03-08       Impact factor: 17.173

10.  ASTROCYTES: EMERGING STARS IN LEUKODYSTROPHY PATHOGENESIS.

Authors:  Angela Lanciotti; Maria Stefania Brignone; Enrico Bertini; Tamara C Petrucci; Francesca Aloisi; Elena Ambrosini
Journal:  Transl Neurosci       Date:  2013-06-01       Impact factor: 1.757

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.